Biopharma Strategies for U.S. Regulatory and Pricing Shifts

The biopharma industry must prepare for significant biopharma regulatory changes and shifts in U.S. drug pricing policy. Proactive measures include monitoring policy developments, engaging stakeholders, and refining pricing strategies. Legislative reforms may affect market access, reimbursement, and innovation incentives. For more info :https://www.zs.com/insights/ho....w-biopharma-should-p